If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Ritchie is the Theme Leader of the Drug Discovery Biology Theme in the Monash Institute of Pharmaceutical Sciences (MIPS), and holds an NHMRC Senior Research Fellowship. Professor Ritchie is internationally-recognised for her contributions to cardiac pharmacology. Her translationally-focused research objective is the identification of new treatment strategies for arresting the progression of heart failure, particularly in the context of diabetes and myocardial infarction. Professor Ritchie’s PhD focused on predictors of myocardial function in vivo in patients with ischaemic heart disease (University of Adelaide 1990–94), including development of the first quantitative model of the force-interval relationship in human myocardium. Her postdoctoral training — Wayne State University 1995–97, USA and the Florey Institute 1997–2002 — preceded her recruitment to the Baker Institute in late 2002. She has numerous relevant preclinical in vivo models of diabetic (T1D, T2D), ischaemic, and other cardiomyopathies in her laboratory.

The research achievements of Professor Ritchie to date include almost 100 career publications and continuous peer-reviewed funding since 1999 (comprising support from NHMRC, Diabetes Australia and the Heart Foundation). Her contributions to cardiac pharmacology have been recognised by the 2012 Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Achievement Award, the 2013 Diabetes Australia Millenium-Type 1 Diabetes Award, and election as a Fellow of the American Heart Association in 2013. Her international profile in her chosen field has been further recognised by numerous prestigious speaking invitations, including multiple World Congresses, including Cardiology, Diabetes, Pharmacology, and the International Society for Heart Research, as well as the American Heart Association and the British Pharmacology Society.


  • NHMRC Level A Senior Research Fellowship (2014–18)
  • American Heart Association International Fellow (2013– )
  • NHMRC Senior Research Fellowship Level A (2008)
  • NHMRC Biomedical Career Development Award (2002)
  • Foundation for High Blood Pressure Research Fellowship (2000)


  • Diabetes Australia Research Trust Millennium Award, Type 1 diabetes (2013)
  • ASCEPT Achievement Award for services to Australasian pharmacology and to scientific discipline/policy over the last 10 years (2012)
  • Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) New Investigator Award (1998)

Research interests

Professor Ritchie leads the Heart Failure Pharmacology laboratory at Monash Institute of Pharmceutical Sciences. Click here to access the laboratory's homepage. 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Cardiology, Ph.D., University of Adelaide

Award Date: 10 Oct 1994

Clinical and Experimental Pharmacology, B.Sc. (Hons)., University of Adelaide

… → 1989

External positions

Co-Director of Drug Discovery and Translation Flagship, Australian Cardiovascular Alliance

2019 → …

Adjunct Professor, Baker Heart and Diabetes Institute

2019 → …

Adjunct Professor, School of Life Sciences, La Trobe University

2018 → …

Member, Management Round Table, Baker Heart and Diabetes Institute


Adjunct Professor, Dept of Pharmacology & Therapeutics, University of Melbourne

2017 → …

Research area keywords

  • cardiac pharmacology
  • new treatment strategies
  • predictors of myocardial function
  • ischaemic heart disease
  • cardiac myocytes
  • diabetic complications
  • hypertrophy


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or